Beranda › Infeksi COVID-19 dan Coronavirus › New York
Uji klinis Infeksi COVID-19 dan Coronavirus di New York
6 studi untuk Infeksi COVID-19 dan Coronavirus mencari peserta di lokasi di New York.
Kota di New York
Teks studi resmi (Bahasa Inggris)
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
- Columbia University Medical Center, New York
Menerima pesertaStudi observasional
Usia 7 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT04448145Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Buffalo
- Research Site, New York
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05624450Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- NYU Langone Health - Brooklyn, Brooklyn
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06631287A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Upstate Global Health Institute, East Syracuse
- Upstate Connect Care, Syracuse
- Prime Global Research, The Bronx
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06679140Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- Weill Cornell Medical College, New York
Menerima pesertaFase 3
Semua usia · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT03808922ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
- NewYork-Presbyterian Hosptial/Columbia University Irving Medical Center, New York
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Apr 2026 · NCT04367857Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.